Cysteine Reactivity Profiling Illuminates Monoclonal Antibody Disulfide Bond Reduction Mechanisms in
Taku Tsukidate1, Zhenshu Wang2, Andrew Hsieh2
1Analytical Research & Development Mass Spectrometry, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States.
None:
Monoclonal antibodies (mAbs) are crucial biotherapeutics in the face of increasing global demand, but their production can be impacted by the reduction of disulfide bonds. This study presents a chemical proteomics workflow aimed at elucidating the mechanisms underlying disulfide bond reduction in mAbs produced from Chinese hamster ovary (CHO) cells. We employed iodoacetamide-desthiobiotin (IA-DTB) and the parallel accumulation and serial fragmentation combined with data-independent acquisition (diaPASEF) methodology for cysteine reactivity profiling and successfully quantified approximately 4,500 cysteine-containing peptides from harvested cell culture fluids (HCCF). Our findings reveal that various protein disulfide oxidoreductases were active in reducing HCCF, offering critical insights into the redox environment affecting mAb stability. Notably, we quantified specific cysteine residues in enzymes such as glutaredoxin and thioredoxin domain-containing protein 12, suggesting potential links between their activity and disulfide bond dynamics. This workflow not only complements conventional abundance proteomics but also enhances our understanding of functional enzyme states in bioprocessing. Ultimately, our approach provides a promising strategy for assessing enzymes contributing to disulfide bond reduction, paving the way for improved manufacturing processes of mAbs.
More Related Videos
11:44Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities
Published on: October 2, 2018
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
Related Concept Videos
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Drug Metabolism: Phase II Reactions
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
